🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP

RecruitingNAAges 18 Years - 84 YearsAllKocaeli University
NCT07611903 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Endoscopic retrograde cholangiopancreatography (ERCP) procedures are commonly performed under deep sedation and are associated with a risk of hypoxemia, particularly in prone or semi-prone positions. High-flow nasal cannula (HFNC) therapy may improve oxygenation by delivering heated and humidified oxygen at high flow rates, while the Microstream Advance nasal cannula provides simultaneous nasal oxygen delivery and oral oxygen insufflation. This prospective randomized study aims to compare the effectiveness of HFNC and Microstream Advance nasal cannula in maintaining oxygenation during ERCP procedures. Patients undergoing ERCP will be randomized into two groups receiving either HFNC or Microstream Advance nasal cannula oxygen support during sedation. The primary outcomes are the incidence of desaturation and oxygen reserve index (ORi) measurements during the procedure. Secondary outcome

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 to 84 years * ASA physical status I-III * Patients scheduled to undergo ERCP * Patients who provide written informed consent Exclusion Criteria: * Recent history of upper respiratory tract infection * History of lung cancer * Chronic obstructive pulmonary disease * Asthma * Body mass index greater than 35 kg/m² * Refusal to participate in the study
💊

What it tests

  • High-flow nasal canula
  • Microstream advance nasal cannula
📍

Where

1 site
Kocaeli University Faculty of Medicine Hospital
Kocaeli, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy